Free initial consultationPRC-licensed physiciansCold-chain delivery nationwide
lab63
Ask a doctor
Performance · Rx onlyCJC—02

CJC-1295

with IpamorelinGHRH analogue + ghrelin mimetic — the GH stack

Growth-hormone-releasing therapy to support your body’s own GH pulses — sleep, recovery, and body composition, monitored against your labs.

Nightly micro-dose12-week courseIGF-1 at baseline · 6 · 12 wkPhysician-supervised
Check your eligibilityRead the clinical reference →
The evidence5×

CJC-1295 raised GH secretion up to five-fold in early clinical studies — by amplifying your own nightly pulses rather than replacing them. Long-term outcome evidence is limited, and your physician will be direct about what is and isn’t established.

Candidacy

Who this is for

Adults with declining recovery, sleep quality, or body composition where labs support GH-axis therapy. Candidacy is decided by your physician against your history and IGF-1, never by a checkout flow.

Often appropriateRecovery and sleep degrading despite structured trainingLow-normal IGF-1 with symptoms to matchBody-composition goals with training already in place
Not appropriateActive or recent malignancy — GH signalling is contraindicatedPregnancy or breastfeedingUntreated sleep apnoea or unexplained symptoms — investigate first
Surfer at dusk, long exposure
Recover like you used toDeep sleep does the heavy lifting. This helps it.
The program

How the program works

01
Day 0Free video consultation

A PRC-licensed physician reviews your goals, history, and whether this therapy is appropriate. If it isn't, you'll hear that instead.

02
Week 1Baseline labs & first dose

An at-home blood draw establishes your baseline. Your pen ships cold-chain once your physician signs the prescription.

03
Weeks 2–12Nightly dosing & check-ins

A small dose before bed, timed to your natural GH pulse. Video review at week 6, messaging in between.

04
Week 12Full review

IGF-1 and symptoms reviewed against baseline. Together you decide: continue, adjust, or taper off with a plan.

Included

What’s included

Single-patient pen, named prescriptioncGMP facility
Cold-chain delivery to your door1–2 days, Metro Manila
IGF-1 panels through the coursebaseline, wk 6, 12
Video reviews through the coursenamed physician
Sleep and training guidanceevery check-in

No prices on this site by design — your program is quoted in full after your consultation, before anything is dispensed.

Questions

Common questions

Sleep depth often shifts within weeks; body-composition changes are slower and tracked at your IGF-1 reviews. Your physician measures rather than promises.

Find out if this fits youFree 20-min video consultation
Book

Often combined with

All →
LongevityNAD+ 1000Cellular energy support alongside performance programs.RecoveryBPC157 & TB500Repair peptide protocol often paired during training phases.
DiagnosticsBaseline longevity panelThe blood work every program starts from.
The science

Two routes to the same axis

CJC-1295 GHRH receptor agonism

CJC-1295 is a synthetic analog of the first 29 amino acids of native GHRH (GRF 1-29), with stabilising amino-acid substitutions at positions 2, 8, 15, and 27 to extend serum half-life relative to native GHRH. The compound binds the growth hormone releasing hormone receptor on anterior pituitary somatotroph cells and stimulates pulsatile GH release.

Ipamorelin GH secretagogue activity

Ipamorelin binds the growth hormone secretagogue receptor (GHSR-1a, the ghrelin receptor) and stimulates GH release. Unlike earlier GH secretagogues, ipamorelin has minimal effect on ACTH or cortisol release (Raun et al, Eur J Endocrinol, 1998;139(5):552-561), giving it the "selective" designation.

Parallel-pathway combination rationale

CJC-1295 acts at the GHRH receptor. Ipamorelin acts at the growth hormone secretagogue receptor. The two receptors trigger GH release through distinct upstream pathways that converge on the somatotroph. Combination protocols are used to probe synergistic activation of GH secretion via parallel pathway engagement.

CJC - 1295 is also searched as Mod GRF 1-29, CJC1295, Ipamorelin.